Lansoprazole‐based sequential and concomitant therapy for the first‐line <i>Helicobacter pylori</i> eradication

Abstract

First-line lansoprazole-based sequential and concomitant therapy were well-tolerated and comparable in terms of their H. pylori eradication rate.